FDA approves insulin dose calculator that’s connected to a smartphone app

The Food and Drug Administration has approved a mobile system that could simplify diabetes management for some patients.

Doctors treating Type 2 diabetes with long-acting insulin are supposed to instruct patients on how to calculate the proper dosage. They then fine-tune the suggestions based on how well the treatment is working to move blood sugar levels in an appropriate range.

Glooko’s Mobile Insulin Dosing System allows doctors to set a dosage and pulls data from the patient’s glucose monitor to recalculate levels based on the reading. It’s integrated into Glooko’s existing mobile app and sends reminders to patients’ cellphones when it’s time to take another dose.

“There’s an enormous unmet need for both clinicians who aren’t comfortable with dosing and therefore don’t put people on long-acting insulin,” said Glooko CEO Rick Altinger. “It’s a wonderful drug if taken in the right amount at the right time in the right way. This overcomes a big need for clinicians and saves them time. For patients, math is hard.”

Leave a Reply

Your email address will not be published. Required fields are marked *